Moleculin Biotech Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
6.20
18.00
68
Gross Income
-
6.20
18.00
68
SG&A Expense
738.20
3,877.00
8,635.00
14,957
EBIT
738.20
3,883.20
8,653.00
15,025
Unusual Expense
-
-
2,399.00
3,185
Non Operating Income/Expense
-
-
1,247.00
40
Interest Expense
10.10
43.20
-
-
Pretax Income
748.40
3,926.40
9,805.00
11,876
Consolidated Net Income
748.40
3,926.40
9,805.00
11,876
Net Income
748.40
3,926.40
9,805.00
11,876
Net Income After Extraordinaries
748.40
3,926.40
9,805.00
11,876
Net Income Available to Common
748.40
3,926.40
9,805.00
11,876
EPS (Basic)
0.05
0.40
0.53
0.46
Basic Shares Outstanding
14,273.90
9,827.50
18,569.20
25,904.20
EPS (Diluted)
0.05
0.40
0.53
0.46
Diluted Shares Outstanding
14,273.90
9,827.50
18,569.20
25,904.20
EBITDA
738.20
3,877.00
8,635.00
14,957
About Moleculin Biotech
View Profile
